Word

180 LIFE SCIENCES

Status

Pending

Status Code

641

Status Date

Thursday, January 25, 2024

Serial Number

97255692

Mark Type

3000

Filing Date

Monday, February 7, 2022

Trademark Owner History

180 Life Sciences Corp.

Classifications

5 Analgesic preparations; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of inflammation; Pharmaceutical preparations for the treatment of Dupuytren's disease; Pharmaceutical preparations for the treatment of frozen shoulder; Pharmaceutical preparations for the treatment of post-operative delirium; Pharmaceutical preparations for the treatment of post-operative cognitive deficit; Pharmaceutical preparations for the treatment of post-operative cognitive decline; Pharmaceutical preparations for the treatment of non-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment of fibrosis; Pharmaceutical preparations for the treatment of liver fibrosis; Pharmaceutical preparations for the treatment of arthritis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of ulcerative colitis; Pharmaceutical preparations for the treatment of anxiety; Pharmaceutical preparations for the treatment of type 1 diabetes; Pharmaceutical preparations for the treatment of type 2 diabetes; Pharmaceutical preparations for inhibition of tumor necrosis factor (TNF); Pharmaceutical preparations for interacting with nicotine receptors; Pharmaceutical preparations for synthetically simulating non-psychoactive effects of cannabidiol (CBD); Pharmaceutical preparations for liver regeneration; Pharmaceutical preparations for regenerative therapy; Pharmaceutical preparations for acting as an alpha-7nAChR agonist

42 Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the field of inflammatory diseases; Scientific research for medical purposes in the field of treatment of inflammation; Scientific research for medical purposes in the field of Dupuytren's disease; Scientific research for medical purposes in the field of frozen shoulder; Scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline; Scientific research for medical purposes in the field of non-alcoholic steatohepatitis; Scientific research for medical purposes in the field of fibrosis; Scientific research for medical purposes in the field of liver fibrosis; Scientific research for medical purposes in the field of arthritis; Scientific research for medical purposes in the field of pain treatment; Scientific research for medical purposes in the field of ulcerative colitis; Scientific research for medical purposes in the field of treatment of anxiety; Scientific research for medical purposes in the field of inhibition of tumor necrosis factor (TNF) and anti-TNF pharmaceuticals; Scientific research for medical purposes in the field of interactions with nicotine receptors; Scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (CBD); Scientific research for medical purposes in the field of synthetic cannabidiol (CBD) analogs; Scientific research for medical purposes in the field of type 1 diabetes; Scientific research for medical purposes in the field of type 2 diabetes; Scientific research for medical purposes in the field of liver regeneration; Scientific research for medical purposes in the field of regenerative therapy; Scientific research for medical purposes in the field of alpha-7nAChR agonists

The mark consists of the term "180 LIFE SCIENCES" in a stylized block, shaded font, the first character of "LIFE" and of "SCIENCES" being slightly larger than the remaining characters of such terms, and the characters of "180" being larger than the characters of "LIFE SCIENCES", the "0" in "180" being bisected along an axis running from its lower left to its upper right with an outwards-pointing barb appearing on each half, and with two similar but smaller "0" characters at each of the lower left and the upper right of the "0" of "180".
ONE HUNDRED EIGHTY LIFE SCIENCES ONE EIGHT ZERO LIFE SCIENCES
Color is not claimed as a feature of the mark.

Trademark Events

Jan 25, 2024

Notification Of Non-Final Action E-Mailed

Jan 25, 2024

Non-Final Action E-Mailed

Jan 25, 2024

Non-Final Action Written

Jan 17, 2024

Assigned To Examiner

Dec 6, 2023

Assigned To Examiner

Dec 4, 2023

Assigned To Examiner

Jul 18, 2023

Assigned To Examiner

Feb 11, 2022

New Application Office Supplied Data Entered

Feb 10, 2022

New Application Entered